← Open Payments lookup

SUYI PARK: Open Payments

NPI 1932177904 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$267 in 12 payments from 8 companies in 2025. Trend: 2023 $1,326 · 2024 $836 · 2025 $267

Food & beverage: $267
CompanyPaymentsAmount
Indivior Inc.3$78
Dexcom, Inc.2$49
AstraZeneca Pharmaceuticals LP2$43
Gilead Sciences, Inc.1$26
Lilly USA, LLC1$19
Xeris Pharmaceuticals, Inc.1$18
Astellas Pharma US Inc1$18
Novo Nordisk Inc1$15

Products named: SUBLOCADE, Dexcom G6 Transmitter, FARXIGA, AMYVID, RECORLEV, Veozah, BREZTRI, Rybelsus.

Industry payments across MD — which companies pay providers there.